Previously Formed Solid Polymer Chemically Reacted With Carbohydrate Or Derivative Patents (Class 525/54.2)
-
Patent number: 7872072Abstract: The present invention is directed to branched reactive water-soluble polymers comprising at least two polymer arms, such as poly(ethylene glycol), attached to a central aliphatic hydrocarbon core molecule through heteroatom linkages. The branched polymers bear at least one functional group for reacting with a biologically active agent to form a biologically active conjugate. The functional group of the branched polymer can be directly attached to the aliphatic hydrocarbon core or via an intervening linkage, such as a heteroatom, -alkylene-, —O-alkylene-O—, -alkylene-O-alkylene-, -aryl-O—, —O-aryl-, (—O-alkylene-)m, or (-alkylene-O—)m linkage, wherein m is 1-10.Type: GrantFiled: January 20, 2006Date of Patent: January 18, 2011Assignee: Nektar TherapeuticsInventors: Michael David Bentley, Xuan Zhao, Xiaoming Shen, William Dudley Battle, III
-
Publication number: 20110008444Abstract: A composition, which upon activation, spontaneously forms a cross-linked hydrogel in aqueous liquid, includes: a) a formulation containing a hyluronan (HA-formulation) which includes a hyaluronan backbone (HA backbone) and a plurality of a reactive substituent group (reactive HA substituent) which i) is directly attached to the HA backbone, and ii) exhibits the reactive HA-group, and b) a formulation of a homo-multifunctional cross-linking reagent (CLR-formulation) exhibiting a plurality of a reactive group (reactive CLR-group). The two reactive groups are selected as a pair of counterparts that mutually and selectively react with each other to form a linkage structure. The hydrogel contains a cross-linking structure which a) is attached to the hyaluronan via two or more of the linkage structure and is defined by the reagent. The cross-linking structure exhibits a plurality of hydroxyl groups. The composition can be used in vivo or ex vivo as a support matrix.Type: ApplicationFiled: February 13, 2009Publication date: January 13, 2011Applicant: IPR-SYSTEMS SWEDEN ABInventors: Kristoffer Bergman, Tim Bowden, Thomas Engstrand, Jons Hilborn, Dmitri Ossipov
-
Publication number: 20110008912Abstract: Described herein are polymer-coated substrates for binding biomolecules and methods of making and using thereof.Type: ApplicationFiled: September 21, 2010Publication date: January 13, 2011Inventors: Anthony G. Frutos, Joydeep Lahiri, Jinlin Peng, Odessa N. Petzold
-
Publication number: 20110002874Abstract: Biomimetic polymer networks comprising a heteropolymer network having a cavity, the cavity having a selective affinity for a moiety, methods for making biomimetic polymer networks, and methods for using biomimetic polymer networks.Type: ApplicationFiled: July 7, 2010Publication date: January 6, 2011Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Nicholas A. Peppas, James Z. Hilt, Mark E. Byrne
-
Publication number: 20110003937Abstract: To provide a polymer which selectively adsorbs an acidic water-soluble target substance, a polymer which has a specific recognition site for an acidic water-soluble target substance, a production process thereof, and an acidic water-soluble target substance-adsorbing agent. A polymer which selectively adsorbs at least one kind of an acidic water-soluble target substance, in which the polymer has a cross-linked structure formed through a two-step reaction including a Michael addition reaction of a polymer having an amino group and/or imino group with an unsaturated carbonyl cross-linker, and a subsequent radical polymerization.Type: ApplicationFiled: December 2, 2008Publication date: January 6, 2011Applicant: NITTO DENKO CORPORATIONInventor: Tomohiro Kontani
-
Publication number: 20110003936Abstract: Disclosed are soil additives capable of hydrophilizing soil particles and/or increase available water capacity in soil. The soil additive are capable of increasing the available water content/capacity (AWC) in soils, the additive in one embodiment comprising a polymer composition having a hydrophilic portion and a hydrophobic portion, wherein the hydrophobic portion of the copolymer binds with the soil particle surface and the hydrophilic portion of the copolymer can bind with water. This results in the prevention, arrest or decelerated loss of water from the targeted area, for example the plant root zone, which allows for improved water usage efficiency by plants, grasses, vegetation, etc.Type: ApplicationFiled: July 2, 2010Publication date: January 6, 2011Applicant: Rhodia OperationsInventors: Zhiyun Chen, Jean-Christophe Castaing, Marie-Pierre Labeau
-
Patent number: 7863406Abstract: Biodegradable poly(ester-amides) are synthesized from amino acids, diols and dicarboxylic acids where one or both of the diols and dicarboxylic acids contain unsaturation; e.g., from di-p-nitrophenyl dicarboxylates and p-toluenesulfonic acid salts of bis(alpha-amino acid) disesters of diols where one or both of the dicarboxylate and diol moieties contain unsaturation or from di-p-nitrophenyl dicarboxylates, and p-toluene-sulfonic acid salts of bis(alpha-amino acid) diesters of diols and p-toluenesulfonic acid salt of lysine ester where one or both of the dicarboxylate and diol moieties contain unsaturation. The polymers are useful as biodegradable carriers for drugs of other bioactive agents.Type: GrantFiled: May 31, 2005Date of Patent: January 4, 2011Assignee: Cornell Research Foundation, Inc.Inventors: Chih-Chang Chu, Ramaz Katsarava, Kai Guo
-
Publication number: 20100331441Abstract: The present invention relates to functionalizing a surface of an organic material. For example, surfaces of materials having C—H bonds, such as polymers having C—H bonds, can be functionalized. In certain embodiments, a heterobifunctional molecule having a photoactive anchor, a spacer, and a terminal functional group is applied to the surface of an organic material that contains one or more C—H bonds. The heterobifunctional molecule can be bound to any surface having C—H bonds as the photoactive anchor can react with C—H bonds upon irradiation. The terminal functional group has a “click” functionality which can be utilized to functionalize the surface of the organic material with any desired functionalizing moiety having the orthogonal click functionality.Type: ApplicationFiled: June 8, 2010Publication date: December 30, 2010Applicant: Columbia UniversityInventors: Jeffrey LANCASTER, Nicholas J. Turro, Jeffrey T. Koberstein
-
Publication number: 20100330143Abstract: Described herein are composites produced by reacting a first thiolated macromolecule with at least one compound having at least one thiol-reactive electrophilic functional group. The methods described herein permit the cross-linking of a variety of different thiolated macromolecules with one another. The composites described herein have a variety of biomedical and pharmaceutical applications, which are also described herein.Type: ApplicationFiled: April 21, 2010Publication date: December 30, 2010Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Glenn D. Prestwich, Aleksander Skardal, Jianxing Zhang
-
Patent number: 7858108Abstract: Elutable coatings comprising protein resistant components and bioactive agent on medical devices are disclosed. The elutable coatings comprise labile linkers that can be cleaved under controlled conditions.Type: GrantFiled: October 20, 2004Date of Patent: December 28, 2010Inventors: Jennifer A. Neff, Karin D. Caldwell, Jonas Andersson, Bo Nilsson, Kristina Nilsson-Ekdahl
-
Publication number: 20100324215Abstract: A method for producing affinity binders having affinitive or highly affinitive binding structures for non-covalent interaction types includes a) contacting a target substance with at least one ligand which is capable of non-covalently binding to the target substance for a sufficient time that the at least one ligand can specifically attach to target regions of the target substance and form a ligand-target substance complex; b) embedding the complex in a structure-providing component and fixing by binding the ligand(s) of the complex to the structure-providing component; and c) removing the target substance such that a structure with a defined spatial arrangement of the ligand(s) is formed which has capacity to specifically bind the respective target substance again.Type: ApplicationFiled: November 25, 2008Publication date: December 23, 2010Applicant: Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.Inventors: Heiko Andresen, Frank Bier, Martin Katterle
-
Publication number: 20100310670Abstract: A sustained-release microsphere formulation containing a short chain deoxyribonucleic acid or a short chain ribonucleic acid as an active ingredient, which has improved sustained-release properties and long-lasting efficacy, is provided. A fine particle formulation, encapsulating stably a short chain deoxyribonucleic acid or a short chain ribonucleic acid, being capable of inhibiting, for a long period, expression of a specific protein related to a disease, and which can be administered by injection or transmucosally, and a production method of the same are provided.Type: ApplicationFiled: March 3, 2006Publication date: December 9, 2010Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Hiroaki Okada, Yuki Takashima, Naoyuki Murata
-
Publication number: 20100311902Abstract: Highly dispersible inorganic compound nanoparticles modified by functional molecules include the functional molecules; a high molecular nitrogen compound having at least two amino groups selected from primary amino groups, secondary amino groups and tertiary amino groups; and inorganic compound nanoparticles bonded to at least one amino group of the at least two amino groups. The high molecular nitrogen compound is modified by the functional molecules, and the inorganic compound nanoparticles are covered with the high molecular nitrogen compound modified by the functional molecules.Type: ApplicationFiled: September 14, 2006Publication date: December 9, 2010Applicant: PENTAX CORPORATIONInventors: Akira YAMAMOTO, Yusuke IIMORI, Mae KOYAMA
-
Publication number: 20100311903Abstract: The present invention provides optical agents comprising optically functional cross linked supramolecular structures and assemblies useful for a range of imaging, diagnostic, and therapeutic applications. Supramolecular structures and assemblies of the present invention include optically functional shell-cross linked micelles wherein optical functionality is achieved via incorporation of one or more linking groups that include one or more photoactive moieties. The present invention further includes imaging, sensing and therapeutic methods using one or more optical agents of the present invention including optically functional shell cross-linked micelles. The present invention includes in situ monitoring methods, for example, wherein physical and/or structural changes in an optically functional shell-cross linked micelle generated in response to changes in chemical environment or physiological conditions causes a measurable change in the wavelengths or intensities of emission from the micelle.Type: ApplicationFiled: November 7, 2008Publication date: December 9, 2010Inventor: Raghavan Rajagopalan
-
Publication number: 20100301257Abstract: This invention relates to monodisperse cross-linked polymer particles, comprising particles with a substantially smooth outer surface and an average diameter of less than 1 ?m, wherein the particles are solid or porous, and wherein the coefficient of variation (CV) % of the particles, when measured by CPS disk centrifugation analysis, is less than 15%. These monodisperse cross-linked polymer particles may comprise magnetic material and are useful in various application. This invention also relates to monodisperse polymer particles for use as seed particles in the Ugelstad process.Type: ApplicationFiled: April 29, 2010Publication date: December 2, 2010Applicant: Invitrogen Dynal ASInventors: Grete Irene Modahl, Geir Fonnum, Astrid Molteberg, Silje Lien, Nini Hofslokken Kjus
-
Publication number: 20100294725Abstract: The present invention relates to polysaccharides that have been modified by providing azetidinium functionality thereto. Such functionality can be provided by crosslinking a polysaccharide with a resin having azetidinium functional groups. In one or more aspects, the polysaccharide can comprise one or more of starch, guar gum, alginate or derivatives thereof. Polysaccharides having azetidinium functionality according to the present invention are suitable for multiple uses. Such uses include, but are not limited to, removal of one or more solid materials from a liquid, beneficiation of an ore, removal of metallic ions from a liquid; providing oil from bitumen; and removal of mercury from synthetic gypsum. Other uses of the functionalized polysaccharides of the present invention include hydroseeding, dust control and corosion control.Type: ApplicationFiled: October 17, 2008Publication date: November 25, 2010Applicant: GEORGIA-PACIFIC CHEMICALS LLCInventors: Michael J. Bush, John B. Hines, James T. Wright
-
Patent number: 7838595Abstract: The present invention is directed to alkanal derivatives of water-soluble polymers such as poly(ethylene glycol), their corresponding hydrates and acetals, and to methods for preparing and using such polymer alkanals. The polymer alkanals of the invention are prepared in high purity and exhibit storage stability.Type: GrantFiled: January 28, 2009Date of Patent: November 23, 2010Assignee: Nektar TherapeuticsInventor: Antoni Kozlowski
-
Patent number: 7838592Abstract: There is provided a starch-based coating composition with excellent storage stability as a one-pack type paint, which can form coating films with excellent drying property, finished appearances, pencil hardness, mar resistance, adhesion, alkali resistance, solvent resistance and weather resistance, as well as coated articles that have been coated with the starch-based coating composition. The starch-based coating composition comprises as the binder a resin composition obtained by reacting (A) starch and/or modified starch with (B) an isocyanate group-containing compound obtained by reacting a polyisocyanate compound (b1) and a polyhydric alcohol (b2), or by reaction of these components with a resin obtained by radical polymerization of a mixture comprising an aromatic-based radical polymerizing unsaturated monomer, a hydroxyl group-containing radical polymerizing unsaturated monomer and optionally another radical polymerizing unsaturated monomer.Type: GrantFiled: June 6, 2007Date of Patent: November 23, 2010Assignee: Kansai Paint Co., Ltd.Inventors: Chikara Kawamura, Kenichi Umezawa
-
Publication number: 20100292402Abstract: The present invention provides a composition comprising a first polymer and a second polymer cross-linked by the association of functional groups attached as side chains to the polymers.Type: ApplicationFiled: March 16, 2010Publication date: November 18, 2010Applicant: Lucent Technologies Inc.Inventors: Allen P. Mills, JR., Bernard Yurke
-
Patent number: 7834088Abstract: The invention provides reagents and methods for conjugating a polymer specifically to the ?-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs and related polymers having a terminal thioester moiety capable of specifically conjugating to the ?-amine of a polypeptide having a cysteine or histidine residue at the N-terminus. The invention provides reactive thioester-terminated PEG polymers that have suitable reactivity with an N-terminal cysteine or histidine residue of a polypeptide to produce an amide bond between the PEG molecule and the polypeptide.Type: GrantFiled: February 17, 2009Date of Patent: November 16, 2010Assignee: Nektar TherapeuticsInventors: Michael J. Roberts, Zhihao Fang
-
Publication number: 20100285111Abstract: Nanoparticles containing nucleic acid and suitable for use as in vivo delivery agents for nucleic acids are provided. The nanoparticles use a covalent conjugate of a polycation such as polyethylenimine and phospholipids. The final DNA-containing nanoparticle has a vesicular structure with a polyplex core surrounded by a mixed lipid/PEG-lipid monolayer envelope and offers simple preparation, high loading capacity, and in vivo stability. The nanoparticles have good in vivo stability and a prolonged blood circulation time and can effectively deliver a gene to a biological target such as a tumor.Type: ApplicationFiled: November 10, 2008Publication date: November 11, 2010Applicant: Northeastern UniversityInventors: Young Tag Ko, Amit Kale, Vladimir Torchilin
-
Publication number: 20100280177Abstract: An organized mobile multicomponent conjugate (OMMC) and method of using to enhance binding of weakly binding compounds to a target. A lamellar structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure, forming a cooperative ensemble that is capable of binding with enhanced affinity to a complementary affinity site on a target. Each binding compound is bound to the lamellar surface, and may be connected by a linker. The OMMC may contain an effector molecule, such as a diagnostic or therapeutic agent, for administration to a patent who is then diagnosed or treated using the effector molecule.Type: ApplicationFiled: July 12, 2010Publication date: November 4, 2010Applicant: MALLINCKRODT INC.Inventors: Gary L. Cantrell, B. Daniel Burleigh
-
Publication number: 20100249321Abstract: Ethylenically unsaturated, particularly acrylic, monomers are polymerised using a catalyst system including a manganese carbonyl initiator, an organic halogen reactive substrate and an allylic halide chain termination agent. Desirably the manganese carbonyl initiator is a dimanganese compound, particularly dimanganese decacarbonyl (Mn2(CO)10). The catalysis mechanism appears to involve initiator homolysis, abstraction of halogen from the reactive substrate forming an organic free radical which acts as a chain initiator for polymerisation and eventual reaction of the propagating chain radical with the chain terminating agent. The speed or extent of reaction may be modified by the inclusion of Lewis acids in the reaction mixture. The resulting polymers are telechelic and may have different end groups. The polymers can be reacted further to functionalise them and/or to form block copolymers.Type: ApplicationFiled: June 9, 2010Publication date: September 30, 2010Applicant: Croda International PLCInventors: Richard J. Harrison, Bruce C. Gilbert, Andrew F. Parsons, Derek J. Irvine
-
Publication number: 20100247826Abstract: Thermoplastic polyolefin polymer composition, polymer chip, fiber, woven or nonwoven fabric, film, closures, laminates can comprise a polymer, a polymer and a nonvolatile polymer-compatible carboxylic acid. Thermoplastic polyolefin polymer composition can also comprise a polymer, a cyclodextrin-modified polymer and a nonvolatile polymer-compatible carboxylic acid. The carboxylic acid moiety of the polymer composition can react with basic materials in the polymer environment and reduce release of the basic material. The cyclodextrin can act to absorb or trap other contaminants or odors in the environment.Type: ApplicationFiled: August 26, 2009Publication date: September 30, 2010Applicant: CELLRESIN TECHNOLOGIES, LLCInventors: Willard E. Wood, Neil J. Beaverson
-
Publication number: 20100249257Abstract: A crystalline polyolefin blend comprising dispersed polyhedral oligomeric silsesquioxane (POSS) nanoparticles has improved packing of chains, high draw-down ratios, as well as improved tensile and yield strength. The blend is made by melt blending the polyolefin with the POSS in the presence of a sorbitol nucleating agent and cooling the mixture so that the nucleating agent serves as a template for the in-situ self assembly of dispersed POSS nanoparticles and the formation of very small crystalline polyolefin sites.Type: ApplicationFiled: November 21, 2008Publication date: September 30, 2010Applicant: UNIVERSITY OF AKRONInventors: Sadhan C. Jana, Byoung-Jo Lee
-
Publication number: 20100240543Abstract: The current invention is a capture-particle comprising: a) a molecular sieve portion; and b) an analyte binding portion; wherein the molecular sieve portion, analyte binding portion or both further comprise a cross-linked region having modified porosity. Capture particles wherein the molecular sieve portion, analyte binding portion or both comprise pore dimensions sufficient to exclude molecules larger than about 60 kDa. These particles are useful in purification and diagnostic methods. Kits comprising the capture particles are also described.Type: ApplicationFiled: September 27, 2006Publication date: September 23, 2010Inventors: Lance Liotta, Emanuel Petricoin, David Geho
-
Publication number: 20100234528Abstract: Universal linkers, their facile processes of manufacture and methods of using the same are provided.Type: ApplicationFiled: March 19, 2010Publication date: September 16, 2010Applicant: Isis Pharmaceuticals, Inc.Inventors: Vasulinga Ravikumar, Muthiah Manoharan, Andrei P. Guzaev, Zhiwei Wang, Raju Krishna Kumar
-
Publication number: 20100227372Abstract: The invention relates to an activated metallic, semiconductor, polymer, composite and/or ceramic substrate, the substrate being bound through a mixed or graded interface to a hydrophilic polymer surface that is activated to enable direct covalent binding to a functional biological molecule, the polymer surface comprising a sub-surface that includes a plurality of cross-linked regions, as well as to such activated substrates that have been functionalised with a biological molecule and to devices comprising such functionalised substrates. Such substrates can be produced by a method comprising steps of: a.Type: ApplicationFiled: July 25, 2008Publication date: September 9, 2010Applicant: The University of SydneyInventors: Marcela Bilek, David McKenzie, Yongbai Yin
-
Publication number: 20100210015Abstract: A water-soluble photo-activatable polymer including: a photo-activatable group adapted to be activated by an irradiation source and to form a covalent bond between the water-soluble photo-activatable polymer and a matrix having at least one carbon; a reactive group adapted to covalently react with a biomaterial for subsequent delivery of the biomaterial to a cell; a hydrophilic group; and a polymer precursor. A composition including a monomolecular layer of the water-soluble photo-activatable polymer and a matrix having at least one carbon, wherein the monomolecular layer is covalently attached to the matrix by a covalent bond between the photo-activatable group and the at least one carbon. The composition further includes a biomaterial having a plurality of active groups, wherein the biomaterial is covalently attached to the monomolecular layer by covalent bonding between the active groups and reactive groups. Also provided is a method for delivery of a biomaterial to a cell.Type: ApplicationFiled: December 8, 2009Publication date: August 19, 2010Applicant: The Children's Hospital of PhiladelphiaInventors: Ivan Alferiev, Ilia Fishbein, Michael Chorny, Robert J. Levy, Benjamin Yellen, Darryl Williams
-
Publication number: 20100210715Abstract: Polymers comprising a polyethylenimine, a biodegradable group, and a relatively hydrophobic group are useful for the delivery of bioactive agents to cells.Type: ApplicationFiled: February 18, 2010Publication date: August 19, 2010Applicant: NITTO DENKO CORPORATIONInventors: Gang Zhao, Xiaoli Fu, Lei Yu
-
Publication number: 20100210588Abstract: The invention concerns a product comprising hyaluronic acid or a salt thereof, wherein the hyaluronic acid has been partially or fully linked or crosslinked with a polymer of an alpha hydroxy acid. The invention also concerns manufacture of the product, uses of the product of the invention in the field of biodegradable plastic materials for the preparation of sanitary and surgical articles, in the pharmaceutical and cosmetic fields; including the various articles made with the same in such fields.Type: ApplicationFiled: March 12, 2010Publication date: August 19, 2010Applicant: Novozymes BioPolymer A/SInventors: Khadija Schwach-Abdellaoui, Michel Vert, Laurent Pravata
-
Publication number: 20100190928Abstract: A polymeric drug in the form of a conjugate of a copolymer of N-(2-hydroxypropyl)-methacrylamide (HPMA) with doxorubicin bound to the polymer via spacers containing hydrolytically cleavable hydrazone bonds, of formula (I), wherein SP1 represents an aminoacyl spacer, x=40 to 335, y=1 to 25, consisting of from 90 to 99.5 mol. % of units of HPMA and 10 to 0.5 mol. % of doxorubicin-containing comonomeric units. The conjugate is prepared via direct copolymerization of the doxorubicin-containing monomer of formula (II) with HPMA.Type: ApplicationFiled: August 8, 2007Publication date: July 29, 2010Inventors: Tomas Etrych, Karel Ulbrich
-
Publication number: 20100184886Abstract: The invention relates to a polysaccharide-g-polyether dispersant represented as a compound of Formula 1 or a mixture of compounds of Formula (I) and Formula (II) wherein, T is the backbone polymer and is a residue of a modified cellulose or chitosan, with a molecular weight of 500-1000,000 g/mol; A and B are each, independently, —O— or —NH—; R is linear or branched —(C1-C50alkylene)-, arylene, cyclo-C5-C8-alkylene, isophoronediyl, or linear or branched —(C2-C10alkylene)- which is interrupted by phenylene or cyclohexanediyl; P is the residue of a polyether and/or polyester chain with molecular weight between 100 and 10,000 g/mol, n is a number of 1-5000.Type: ApplicationFiled: June 26, 2008Publication date: July 22, 2010Inventors: Huiguang Kou, Frank Oliver Heinrich Pirrung, Haiyang Yu, Yinzhi Ma, Petrus Johannes Harbers
-
Publication number: 20100176053Abstract: A modified bioreactor support material having high surface area for removing a contaminant (16) from fluids can include a substrate (10) having a functionalized surface, The functionalized surface can have inorganic or organic non-living functional groups, such that the functional groups bind to or chemically alter the contaminant. A method for making a modified bioreactor support material can include activating a suitable substrate (10) and attaching a biologically-derived functional group carrier such as living microbes (18) or non-living materials (14) derived from living materials to the activated substrate (10).Type: ApplicationFiled: March 28, 2008Publication date: July 15, 2010Inventors: D. Jack Adams, Jan D. Miller
-
Publication number: 20100179284Abstract: Medical device, prosthesis, or packaging assembly made up of polymer body comprising at least one polymer having the formula R(LE)x wherein R is a polymeric core having a number average molecular weight of from 5000 to 7,000,000 daltons, and having x endgroups, x is an integer?1, E is an endgroup which is covalently linked to polymeric core R by linkage L, L is a divalent oligomeric chain which has at least 5 repeat units and which can self-assembly with L chains on adjacent molecules of the polymer, and moieties L and/or E in the polymer(s) may be the same as or different from one another in composition and/or molecular weight. The polymer body includes plural polymer molecules located internally within the body, at least some of which internal polymer molecules have endgroups that form a surface of the body. The surface endgroups include at least one self-assembling moiety.Type: ApplicationFiled: May 28, 2008Publication date: July 15, 2010Applicant: DSM IP ASSETS B.V.Inventors: Robert S. Ward, Keith McCrea, Yuan Tian, Shanger Wang, Larry Jones, Anfeng Wang, James P. Parakka
-
Publication number: 20100168331Abstract: A thermoplastic resin composition of the present invention has high impact resistance, not lowering the weather resistance thereof, even though the amount of an impact resistance improver added thereto is small. The thermoplastic resin composition contains 100 parts by weight of (A) a thermoplastic resin and from 0.5 to 20 parts by weight of (B) a graft copolymer, wherein the graft copolymer (B) contains from 70% to 99% by weight of a crosslinked core (b2) prepared through polymerization of a monomer for the core (b2), containing 70% by weight or more of an acrylate, in the presence of from 0.5% to 20% by weight of a non-crosslinked seed (b1) having a weight-average molecular weight of 40,000 or less, and from 0.5% to 10% by weight of a shell (b3) prepared through polymerization of a monomer for the shell (b3) containing 50% by weight or more of a methacrylate, and the thermoplastic composition further contains from 0.01 to 3.Type: ApplicationFiled: February 7, 2007Publication date: July 1, 2010Inventor: Toru Terada
-
Publication number: 20100166607Abstract: Methods and apparatus are provided for manufacturing an analyte detecting device. In one embodiment, the method comprises providing a substrate, applying a plurality of layer of materials on said substrate; applying a layer containing at least one mediator; and screen printing a hydrogel on the layer.Type: ApplicationFiled: May 20, 2005Publication date: July 1, 2010Inventor: Norbert Bartetzko
-
Publication number: 20100159019Abstract: The invention provides a block copolymer comprising at least a first block and a second block. The first block comprises a plurality of temperature-sensitive monomeric units, a plurality of hydrophilic monomeric units and a plurality of targeting monomeric units, and the second block comprises a plurality of hydrophobic monomeric units. The second block comprises at least one pH-sensitive moiety.Type: ApplicationFiled: July 5, 2006Publication date: June 24, 2010Inventors: Yi-Yan Yang, Shao-Qiong Liu
-
Publication number: 20100150832Abstract: The present invention relates to biodegradable biocompatible polyketals, methods for their preparation, and methods for treating animals by administration of biodegradable biocompatible polyketals. In one aspect, a method for forming the biodegradable biocompatible polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a reducing agent to form the biodegradable biocompatible polyketal. The resultant biodegradable biocompatible polyketals can be chemically modified to incorporate additional hydrophilic moieties. A method for treating animals includes the administration of the biodegradable biocompatible polyketal in which biologically active compounds or diagnostic labels can be disposed. The present invention also relates to chiral polyketals, methods for their preparation, and methods for use in chromatographic applications, specifically in chiral separations.Type: ApplicationFiled: November 18, 2009Publication date: June 17, 2010Applicant: The General Hospital CorporationInventor: Mikhail I. Papisov
-
Patent number: 7737240Abstract: The present invention relates to a new hydrogel functionalized with a polymerizable moiety, the polymerized hydrogels, films and gels comprising the same and their use for cells, proteins, DNA or other molecules encapsulation, including use as biosensors or bioreactors.Type: GrantFiled: March 3, 2008Date of Patent: June 15, 2010Assignees: Universite Joseph Fourier-Grenoble 1, Ben-Gurion University of the Negev Research and Development AuthorityInventors: Robert Marks, Serge Cosnier, Boris Polyak, Elena Rodica Ionescu, Khalil Abu-Rabeah
-
Publication number: 20100140112Abstract: A diagnostic kit disclosed herein comprises a nanoparticle-biomaterial complex, an extraction solution, a collection electrode, and a current peak measurement unit. The nanoparticle-biomaterial complex comprises: one or more nanoparticles selected from a metal group consisting of zinc, cadmium, lead, copper, gallium, arsenic, thallium, nickel, manganese and bismuth; one or more biomaterial-binding materials binding to the nanoparticles through a binding-stabilizing agent and binding specifically to the biomaterials to be detected; and a binding-stabilizing agent forming bonds between the nanoparticles and the biomaterial-binding materials. The extraction solution serves to isolate and extract the nanoparticles from the nanoparticle-biomaterial complex. The collection electrode serves to collect the nanoparticles from the extraction solution. The current peak measurement unit serves to measure current peaks corresponding to the nanoparticles collected from the collection electrode.Type: ApplicationFiled: June 23, 2006Publication date: June 10, 2010Inventors: Kyoung-Sik Seo, Jeong-Whan Kim
-
Publication number: 20100137474Abstract: In various aspects provided are methods for producing a nanoparticle within a cross-linked, collapsed polymeric material. In various embodiments, the methods comprise (a) providing a polymeric solution comprising a polymeric material; (b) collapsing at least a portion of the polymeric material about one or more precursor moieties; (c) cross-linking the polymeric material; (d) modifying at least a portion of said precursor moieties to form one or more nanoparticles and thereby forming a composite nanoparticle.Type: ApplicationFiled: May 16, 2007Publication date: June 3, 2010Applicant: NORTHERN NANOTECHNOLOGIESInventors: Cynthia M. Goh, Jose Arnado Dinglasan, Jane B. Goh, Richard Loo, Darren Anderson
-
Publication number: 20100136614Abstract: Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. The nucleic acids are used to form dendrimers that are useful as supports, vectors, carriers or delivery vehicles for a variety of compounds in biomedical and biotechnological applications. In particular, the macromolecules may be used for the delivery of drugs, genetic material, imaging components or other functional molecule to which they can be conjugated. An additional feature of the macromolecules is their ability to be targeted for certain organs, tumors, or types of tissues. Methods of utilizing such biomaterials include delivery of functional molecules to cells.Type: ApplicationFiled: October 18, 2006Publication date: June 3, 2010Inventors: Dan Luo, Yougen Li
-
Publication number: 20100135909Abstract: A metal treatment composition including Tin (II) Chloride and processed montmorillonite clay. The addition of Tin (II) Chloride to the composition provides Tin for forming a ceramic-metal layer on the surfaces of the friction pair. Tin (II) Chloride provides Chlorine ions for forming Chloric films for protecting juvenile surfaces which form in the friction zone. The clay is heated and pulverized to produce a powder comprising both particles having crystalline layer structure and salts and oxides. The layered crystalline structure of the clay contains slip planes that transversely shift when tangential pressure from the friction pair is applied thereby lubricating the friction pair. The salts and oxides contribute to the formation of the ceramic-metal layer.Type: ApplicationFiled: August 16, 2007Publication date: June 3, 2010Inventors: Zheng-Rong Lu, Todd Kaneshiro
-
Patent number: 7723432Abstract: The invention provides a method for preparing a 1-benzotriazolylcarbonate ester of a water-soluble and non-peptidic polymer by reacting a terminal hydroxyl group of a water-soluble and non-peptidic polymer with di(1-benzotriazolyl)carbonate in the presence of an amine base and an organic solvent. The polymer backbone can be poly(ethylene glycol). The 1-benzotriazolylcarbonate ester can then be reacted directly with a biologically active agent to form a biologically active polymer conjugate or reacted with an amino acid, such as lysine, to form an amino acid derivative.Type: GrantFiled: April 30, 2009Date of Patent: May 25, 2010Assignee: Nektar TherapeuticsInventor: Antoni Kozlowski
-
Patent number: 7713637Abstract: Provided herein are a coating or a device (e.g., absorbable stent) that includes a PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid biocompatible polymer and the methods of use thereof.Type: GrantFiled: March 3, 2006Date of Patent: May 11, 2010Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Lothar W. Kleiner, Connie S. Kwok
-
Publication number: 20100113695Abstract: Non-viral vectors for delivering agents to a site within the body of an animal comprise a biocompatible nanoparticle conjugated to an avidin/biotin complex and a water soluble linear polymer comprising multiple binding sites. The agents to be delivered are conjugated to each of the multiple binding sites, thereby increasing the loading capacity of the system. Where the agents comprise siRNA, each biotin/avidin complex may carry greater than four siRNA. The biocompatible nanoparticle may also comprise a fluorescent dye for in vivo imaging.Type: ApplicationFiled: September 18, 2009Publication date: May 6, 2010Inventors: Rao Papineni, Tao Ji, William E. McLaughlin
-
Publication number: 20100105835Abstract: The present invention provides a molded article of a resin containing poly-L-lactic acid, which is excellent in heat resistance and drop impact resistance. There is disclosed a molded article characterized in that said molded article is made from a resin composition obtained by compounding a functional filler into a resin made from a poly-L-lactic acid, the functional filler being yielded by a copolymerization of a compound having 2-4 hydroxyl groups with 1-100 molecules of D-lactic acid and a low-molecular-weight polymer selected from a group consisting of glycols, aliphatic polyesters and aromatic polyesters. The resin molded article according to the present invention exerts excellent drop impact resistance without sacrificing heat resistance.Type: ApplicationFiled: May 27, 2008Publication date: April 29, 2010Applicant: YOSHINO KOGYOSHO CO., LTD.Inventors: Shuichi Kitora, Masato Suzuki
-
Publication number: 20100105796Abstract: The present invention is directed to methods and materials for producing complements and reproductions of a master, including such preparation in a high throughput setting, using, inter-alia, liquid supramolecular nanostamping (LiSuNS).Type: ApplicationFiled: August 23, 2007Publication date: April 29, 2010Inventors: Francesco Stellacci, Arum Amy Yu
-
Publication number: 20100105089Abstract: A biotag that includes a biomolecule that includes a bio polymer sequence; an attaching polymer attached at an endpoint of the biopolymer sequence; and a quantum dot bound to the attaching polymer causing the attaching polymer to become fluorescently labeled is provided. Suggested biomolecules include, but are not limited to, peptides, proteins, amino acids, nucleic acids, deoxyribonucleic acids, ribonucleic acids, and peptide nucleic acids. The biopolymer sequence may be or otherwise include a protein sequence. The biomolecule may be located inside a cell, outside a cell, or on a cell. Desirably, a quantum dot is bound to an attaching polymer and, thus the biomolecule, without using any of thiol chemistries, 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide/N-hydroxysuccinimide hydrochloride (EDC/NHS) chemistries, and biotin/avidin chemistries.Type: ApplicationFiled: September 30, 2009Publication date: April 29, 2010Inventor: LETHA J. SOOTER